Your browser doesn't support javascript.
loading
Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein.
Zhang, Jun; Tang, Weichun; Gao, Hailong; Lavine, Christy L; Shi, Wei; Peng, Hanqin; Zhu, Haisun; Anand, Krishna; Kosikova, Matina; Kwon, Hyung Joon; Tong, Pei; Gautam, Avneesh; Rits-Volloch, Sophia; Wang, Shaowei; Mayer, Megan L; Wesemann, Duane R; Seaman, Michael S; Lu, Jianming; Xiao, Tianshu; Xie, Hang; Chen, Bing.
Afiliação
  • Zhang J; Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Tang W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Gao H; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.
  • Lavine CL; Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Shi W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Peng H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Zhu H; Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Anand K; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Kosikova M; Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Kwon HJ; Institute for Protein Innovation, Harvard Institutes of Medicine, Boston, MA, USA.
  • Tong P; Institute for Protein Innovation, Harvard Institutes of Medicine, Boston, MA, USA.
  • Gautam A; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.
  • Rits-Volloch S; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.
  • Wang S; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Mayer ML; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Wesemann DR; Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Seaman MS; Codex BioSolutions, Inc., Rockville, MD, USA.
  • Lu J; The Harvard Cryo-EM Center for Structural Biology, Boston, MA, USA.
  • Xiao T; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Xie H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Chen B; Codex BioSolutions, Inc., Rockville, MD, USA.
Nat Struct Mol Biol ; 30(7): 980-990, 2023 07.
Article em En | MEDLINE | ID: mdl-37430064
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Struct Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Struct Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos